PACS Group, Inc. (New York Stock Exchange:PACS)
| Market Cap | 6.78B+209.1% |
| Revenue (ttm) | 5.55B+15.2% |
| Net Income | 269.17M+103.5% |
| EPS | 1.67+103.7% |
| Shares Out | 158.34M |
| PE Ratio | 25.18 |
| Forward PE | 16.34 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 917,614 |
| Open | 43.19 |
| Previous Close | 42.71 |
| Day's Range | 42.52 - 43.85 |
| 52-Week Range | 10.31 - 49.49 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 56.67(+32.38%) |
| Earnings Date | Nov 9, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About PACS
PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PACS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in PACS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PACS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PACS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PACS Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Medicaid | $561.05M | 39.30% |
| Medicare | $487.31M | 34.14% |
| Managed care | $283.10M | 19.83% |
| Private and other | $96.03M | 6.73% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PACS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PACS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PACS
| ETF | Est. Holding Size |
|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | $53.25M |
| VTIVanguard Morningstar Total Stock Market ETF | $53.18M |
| IWMiShares Russell 2000 ETF | $51.84M |
| VBVanguard Morningstar Small-Cap ETF | $38.48M |
| DFASDimensional - US Small Cap ETF | $26.29M |
| VXFVanguard Extended Market ETF | $21.81M |
Estimated from each fund’s disclosed top holdings × AUM
PACS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PACS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score